Guideline-Recommended Treatments for HER2-Negative Metastatic Breast Cancer

Treatment for HER2-negative metastatic breast cancer depends on factors like hormone receptor status, with chemo/immunotherapy for PD-L1-positive triple negative disease, PARP inhibitors for BRCA mutations, and antibody-drug conjugates as options after first line therapy.

EP: 1.The Role of the HER2 Receptor in Breast Cancer

EP: 2.Necessary Tests After a Diagnosis of Breast Cancer

EP: 3.Factors Informing Individualized Treatment Decision-Making for HER2-Positive Metastatic Breast Cancer

EP: 4.Discussing Clinical Trial Enrollment for HER2-Positive Metastatic Breast Cancer With Your Oncologist

EP: 5.Guideline-Recommended Treatments for HER2-Positive Metastatic Breast Cancer

Now Viewing

EP: 6.Guideline-Recommended Treatments for HER2-Negative Metastatic Breast Cancer

EP: 7.Guideline-Recommended Treatments for HER2-Low Metastatic Breast Cancer

EP: 8.How HER2 Targeted Therapies Fight HER2-Positive Metastatic Breast Cancer

EP: 9.Imaging Scans for Assessing HER2-Positive Breast Cancer Progression and Treatment Response

EP: 10.Potential Severe Side Effects of HER2-Positive Metastatic Breast Cancer Treatment

EP: 11.Collaborating With Your Oncology Care Team to Manage Side Effects of HER2-Positive Metastatic Breast Cancer Treatment

Related Videos

Related Content

Advertisement

July 31st 2025

Building My Medical Team and Support System After a Cancer Diagnosis

Patti McGee

After my cancer diagnosis, I built a strong medical team and support system that helped me heal; reaching out and accepting help made all the difference.

July 31st 2025

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon

One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.

July 31st 2025

True Life Stories About Cancer Can Inspire Others

Bonnie Annis

Watching a true-life story about a woman’s battle with cancer has given me a new perspective on life.

July 31st 2025

Conference Highlights from SABCS

Alex Biese Brielle Benyon

CURE® recently covered the San Antonio Breast Cancer Symposium. In case you missed it, here is some news that came out of the conference that patients should know about.

July 31st 2025

My Passion for Guiding Women With Cancer to Embracing the ‘New You’

Patti McGee

Cancer changed my life and inspired me to guide other women in healing, self-love and rediscovering their strength through massage and coaching.

July 31st 2025

Gedatolisib Triplet Boosts Progression-Free Survival in Breast Cancer

Spencer Feldman

Gedatolisib combined with Faslodex and Ibrance improved progression-free survival in patients with advanced breast cancer after prior therapies.

Related Content

Advertisement

July 31st 2025

Building My Medical Team and Support System After a Cancer Diagnosis

Patti McGee

After my cancer diagnosis, I built a strong medical team and support system that helped me heal; reaching out and accepting help made all the difference.

July 31st 2025

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon

One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.

July 31st 2025

True Life Stories About Cancer Can Inspire Others

Bonnie Annis

Watching a true-life story about a woman’s battle with cancer has given me a new perspective on life.

July 31st 2025

Conference Highlights from SABCS

Alex Biese Brielle Benyon

CURE® recently covered the San Antonio Breast Cancer Symposium. In case you missed it, here is some news that came out of the conference that patients should know about.

July 31st 2025

My Passion for Guiding Women With Cancer to Embracing the ‘New You’

Patti McGee

Cancer changed my life and inspired me to guide other women in healing, self-love and rediscovering their strength through massage and coaching.

July 31st 2025

Gedatolisib Triplet Boosts Progression-Free Survival in Breast Cancer

Spencer Feldman

Gedatolisib combined with Faslodex and Ibrance improved progression-free survival in patients with advanced breast cancer after prior therapies.